NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. (Q40468711)

20 September 2017

NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. (English)

1 reference

20 September 2017

1

Lars Zender

0 references

author name string

Lars Zender

1

1 reference

20 September 2017

Sebastian Hütker

2

1 reference

20 September 2017

Bettina Mundt

3

1 reference

20 September 2017

Morlen Waltemathe

4

1 reference

20 September 2017

Christian Klein

5

1 reference

20 September 2017

Christian Trautwein

6

1 reference

20 September 2017

Nisar P Malek

7

1 reference

20 September 2017

Michael Peter Manns

8

1 reference

20 September 2017

Florian Kühnel

9

1 reference

20 September 2017

Stefan Kubicka

10

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

41

1 reference

20 September 2017

2

1 reference

20 September 2017

280-288

1 reference

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

20 September 2017

1 reference

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

21 January 2018

1 reference

Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis

21 January 2018

1 reference

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

21 January 2018

1 reference

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B

21 January 2018

1 reference

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

21 January 2018

1 reference

NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis

21 January 2018

1 reference

The interplay of DNA-binding proteins on the promoter of the mouse albumin gene.

21 January 2018

1 reference

RNA interference in adult mice.

21 January 2018

1 reference

Caspase 8 small interfering RNA prevents acute liver failure in mice

21 January 2018

1 reference

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes

21 January 2018

1 reference

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

21 January 2018

1 reference

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

21 January 2018

1 reference

NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene

21 January 2018

1 reference

NF-kappaB signals induce the expression of c-FLIP.

21 January 2018

1 reference

RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members

21 January 2018

1 reference

Destabilizing influences in apoptosis: sowing the seeds of IAP destruction

21 January 2018

1 reference

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.

21 January 2018

1 reference

Fas-mediated apoptosis in primary cultured mouse hepatocytes

21 January 2018

1 reference

7 January 2021

Essential roles of the Fas ligand in the development of hepatitis

1 reference

7 January 2021

Contribution of Fas ligand to T cell-mediated hepatic injury in mice

1 reference

7 January 2021

Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice

1 reference

7 January 2021

Involvement of TRAIL and its receptors in viral hepatitis

1 reference

7 January 2021

Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

1 reference

7 January 2021

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

1 reference

7 January 2021

Efficient delivery of siRNA for inhibition of gene expression in postnatal mice

1 reference

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

7 January 2021

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment

1 reference

7 January 2021

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

7 January 2021

TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20566

1 reference

20 September 2017

1 reference